Premium
This is an archive article published on January 13, 2020

Bhim Army chief Chandrashekhar Azad taken to AIIMS for follow-up treatment

In his plea to the court, Chandrashekhar Azad had said he suffered from polycythemia and "requires continuous checkup from the doctors concerned from AIIMS, who are supervising his treatment for a long time."

bsp mayawati, bahujan samaj party, chandrashekhar azad, bhim army, bjp On January 9, a Delhi court had directed Tihar Jail authorities to provide treatment for polycythemia to Chandrashekhar Azad at All India Institute of Medical Sciences in the national capital. (File)

Bhim Army chief Chandrashekhar Azad, arrested in connection with violence during the anti-Citizenship Amendment Act protest in Old Delhi’s Daryaganj, was taken to AIIMS on Monday for “follow-up consultation and treatment”.

Azad is suffering from polycythemia, a condition in which the body makes too many red blood cells.

Sources at AIIMS said Azad has been undergoing treatment at the Department of Hematology for quite some time. “He has been brought for follow-up consultation and treatment. He is undergoing investigations and will be soon sent back,” a source said.

Story continues below this ad

On January 9, a Delhi court had directed Tihar Jail authorities to provide treatment for polycythemia to Azad at All India Institute of Medical Sciences in the national capital.

In his plea to the court, Azad had said he suffered from polycythemia and “requires continuous checkup from the doctors concerned from AIIMS, who are supervising his treatment for a long time.”

If treatment was not provided urgently, it might lead to cardiac arrest, the plea said.

The Bhim Army chief was sent to judicial custody on December 21.

Story continues below this ad

Azad’s outfit had organised a march from Jama Masjid to Jantar Mantar against the amended Citizenship Act on December 20, without police permission.

Stay updated with the latest - Click here to follow us on Instagram

Latest Comment
Post Comment
Read Comments
Advertisement
Loading Taboola...
Advertisement